Table 4 Predicting of first line HAART failure in HIV infected children with HIV/AIDS treated in HIV clinics at Tikur Anbessa Hospital, Addis Ababa, Ethiopia from April 1 to May 15, 2018.(n = 318)
Independent variable | Treatment Failure (%) | Treatment Success (%) | Odds Ratio (95% CI) | Adjusted Odds Ratio (95%CI)a |
|---|---|---|---|---|
Primary Care Taker | ||||
 Both parents | 8(8.08) | 91(91.92) | 1.00 |  |
 Other Care takers | 64(29.22) | 155(70.77) | 3.72 (1.61–8.61) | 2.72 (1.05–7.06)* |
Serology of Care Taker | ||||
 Positive | 32(16.90) | 157(83.06) | 1.00 |  |
 Negative | 15(29.41) | 36(70.50) | 2.27 (1.03–4.99) | 2.69 (1.03–7.03)* |
 Unknown | 25(32.05) | 53(67.95) | 2.12 (1.05–4.27) | 2.26 (0.93–5.49) |
Disclosure to the Child | ||||
 Disclosed | 57(20.2) | 225(79.7) | 1.00 |  |
 Not disclosed | 15(41.6) | 21(58.40) | 2.48 (1.09–5.65) | 1.41 (0.55–3.65) |
Base Line WHO Stage | ||||
 Stage 1 and 2 | 20(10.9) | 162(89.01) | 1.00 |  |
 Stage 3 and 4 | 52(38.2) | 84(61.70) | 5.33 (2.73–10.40) | 3.64 (1.76–7.56)* |
Age at initiation of HAART | ||||
  < =11 month | 37(40.6) | 54(59.30) | 1.00 |  |
 12–34 months | 14(22.22) | 49(77.78) | 0.39 (0.17–0.88) | 0.40 (0.16–0.99)* |
 35–59 months | 14(26.92) | 38(73.08) | 0.49 (0.21–1.14) | 0.55 (0.21–1.43) |
  > = 60 months | 7(6.25) | 105(93.75) | 0.07 (0.02–0.21) | 0.07 (0.02–0.24)* |